Dr Miyabe Shields has a PhD in endocannabinoid pharmsci and is co-creator of 'Network of Applied Pharmacognosy' with Dr. Riley Kirk, a non-profit contributing to education and destigmatising of emerging medicinal natural products. Miyabe is also a thriving queer and neurodivergent Instagram personality with over 40K followers, which is often used to promote 'Project Chronic' from 'Dose Like A Scientist', a community-based educational platform for neurodivergents providing a network, teaching them about pharmacology and advocacy.

Introducing Season 3 of the Thoughty Auti Podcast, Thomas explains the new upload schedule of the podcast before pivoting to the episode topic... Marijuana and Autism. Miyabe gives a brief background to why she chose to pursue Pharamacological research into endocannabinoids before highlighting the differences in the legality and prescription of consumable hemp, recreational, and medical marijuana between the USA and the UK. Two big distinctions were product diversity and black market prevalence in obtaining marijuana. Thomas highlights his introduction to recreational drug users at university, sparking an interest in the physiological and experiential elements of alternative medicine and drug use. He had a very bad association with drug use, personality, work ethic, and intelligence, common to many proclaimed 'tea-total' individuals. Miyabe describes the Stoner Archetype and how it influences public perspectives on marijuana use as opposed to the use of legal highs like alcohol and tobacco. Miyabe explains the Triad Of Suffering, three issues common to neurodivergent individuals, but also something treatable with medical marijuana. Listing off the immediate and long-term potentials of THC and CBD through a medical lens, it's clear this medicine has a lot of therapeutic potential for neurotypical and neurodivergent individuals. A clear advantage to recreational use through the heightening of social rewards and reduced discomfort with eye contact through an oxytocin mediator seemed to explain the positive regard towards marijuana testified by neurodivergents in a social setting. Marijuana is not without potential risks, being linked to triggering schizophrenia, an array of mental illnesses, and neuronal changes in users under the age of 25; although correlation does not always equal causation, it's a clear concern for medical professionals and the public. Touching on the history of hemp and marijuana use, Miyabe details the many reasons why she is fighting for more widespread legalisation of both medicinal and recreational marijuana use. Ignoring its potential benefits, it proves to be a relatively lower toxicity and crime-facilitating option than the socially accepted recreational use of ethanol and nicotine. Whether you agree with legalisation of such a plant, you'll surely take away a lot of new perspectives and information about marijuana use for neurotypical and neurodivergent individuals.